H.R. 3777 · 111th Congress
Drug Price Competition Act of 2009
- Stage
- In committee
- Sponsor
- Alcee Hastings
- Introduced
- 2009-10-08
- Latest action
- 2009-10-09 · Referred to the Subcommittee on Health.
Summary
Drug Price Competition Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant to submit a substantially complete application that contains and lawfully maintains a certification for such drug.